1,936
Views
5
CrossRef citations to date
0
Altmetric
HPV

How to make effective HPV vaccine recommendations starting at age 9

, , , , &
Article: 2216117 | Received 28 Apr 2023, Accepted 17 May 2023, Published online: 29 May 2023

References

  • National HPV Vaccination Roundtable. HPV vaccination starts at age 9. National HPV Vaccination Roundtable; 2021 [accessed 2023 Apr 19]. https://hpvroundtable.org/hpv-vaccination-starts-at-9/.
  • O’Leary ST, Nyquist AC. Why AAP recommends initiating HPV vaccination as early as age 9. American Academy of Pediatrics (AAP) News; 2019 Oct 4 [accessed 2023 Apr 19]. https://publications.aap.org/aapnews/news/14942/Why-AAP-recommends-initiating-HPV-vaccination-as?searchresult=1?autologincheck=redirected.
  • O’Leary ST. Why the American academy of pediatrics recommends initiating HPV vaccine at age 9. Hum Vaccin Immunother. 2022;18(6):2146434. doi:10.1080/21645515.2022.2146434.
  • Meites E, Szilagyi PG, Chesson HW, Unger ER, Romero JR, Markowitz LE. Human papillomavirus vaccination for adults: updated recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep. 2019;68(32):698–5. doi:10.15585/mmwr.mm6832a3. PMID: 31415491.
  • Biancarelli DL, Drainoni ML, Perkins RB. Provider experience recommending HPV vaccination before age 11 years. J Pediatr. 2020;217:92–7. Epub 20191119. doi:10.1016/j.jpeds.2019.10.025. PMID: 31757474.
  • Minihan AK, Bandi P, Star J, Fisher-Borne M, Saslow D, Jemal A. The association of initiating HPV vaccination at ages 9–10 years and up-to-date status among adolescents ages 13–17 years, 2016-2020. Hum Vaccin Immunother. 2023;19(1):2175555. doi:10.1080/21645515.2023.2175555.
  • O’Leary SC, Frost HM. Does HPV vaccination initiation at age 9, improve HPV initiation and vaccine series completion rates by age 13? Hum Vaccin Immunother. 2023;19(1):2180971. doi:10.1080/21645515.2023.2180971.
  • Perkins RB, Legler A, Jansen E, Bernstein J, Pierre-Joseph N, Eun TJ, Biancarelli DL, Schuch TJ, Leschly K, Fenton AT, et al. Improving HPV vaccination rates: a stepped-wedge randomized trial. Pediatrics. 2020;146(1). doi:10.1542/peds.2019-2737. PMID: 32540986.
  • Saxena K, Kathe N, Sardana P, Yao L, Chen Y-T, Brewer NT. HPV vaccine initiation at 9 or 10 years of age and better series completion by age 13 among privately and publicly insured children in the US. Hum Vaccin Immunother. 2023;19(1):2161253. doi:10.1080/21645515.2022.2161253.
  • St Sauver JL, Rutten LJF, Ebbert JO, Jacobson DJ, McGree ME, Jacobson RM. Younger age at initiation of the human papillomavirus (HPV) vaccination series is associated with higher rates of on-time completion. Prev Med. 2016;89:327–33. doi:10.1016/j.ypmed.2016.02.039. PMID: 26930513.
  • Kahn BZ, Reiter PL, Kritikos KI, Gilkey MB, Queen TL, Brewer NT. Framing of national HPV vaccine recommendations and willingness to recommend at ages 9-10. Hum Vaccin Immunother. 2023;19(1):2172276. doi:10.1080/21645515.2023.2172276.
  • Kong WY, Huang Q, Thompson P, Grabert BK, Brewer NT, Gilkey MB. Recommending human papillomavirus vaccination at age 9: a national survey of primary care professionals. Acad Pediatr. 2022;22(4):573–80. doi:10.1016/j.acap.2022.01.008. PMID: 35081470.
  • Brewer NT, Hall ME, Malo TL, Gilkey MB, Quinn B, Lathren C. Announcements versus conversations to improve HPV vaccination coverage: a randomized trial. Pediatrics. 2017;139(1). doi:10.1542/peds.2016-1764. PMID: 27940512.
  • Malo TL, Hall ME, Brewer NT, Lathren CR, Gilkey MB. Why is announcement training more effective than conversation training for introducing HPV vaccination? A theory-based investigation. Implement Sci. 2018;13(1):57. doi:10.1186/s13012-018-0743-8.
  • Brewer NT, Mitchell CG, Alton Dailey S, Hora L, Fisher-Borne M, Tichy K, McCoy T. HPV vaccine communication training in healthcare systems: evaluating a train-the-trainer model. Vaccine. 2021;39(28):3731–6. doi:10.1016/j.vaccine.2021.05.038. PMID: 34078555.
  • Fenton AT, Eun TJ, Clark JA, Perkins RB. Indicated or elective? The association of providers’ words with HPV vaccine receipt. Hum Vaccin Immunother. 2018;14(10):2503–9. doi:10.1080/21645515.2018.1480237. PMID: 29847201.
  • Brewer NT, Chapman GB, Rothman AJ, Leask J, Kempe A. Increasing vaccination: putting psychological science into action. Psychol Sci Public Interest. 2017;18(3):149–207. doi:10.1177/1529100618760521. PMID: 29611455.
  • Opel DJ, Heritage J, Taylor JA, Mangione-Smith R, Salas HS, Devere V, Zhou C, Robinson JD. The architecture of provider-parent vaccine discussions at health supervision visits. Pediatrics. 2013;132(6):1037–46. doi:10.1542/peds.2013-2037. PMID: 24190677.
  • Opel DJ, Mangione-Smith R, Robinson JD, Heritage J, DeVere V, Salas HS, Zhou C, Taylor JA. The influence of provider communication behaviors on parental vaccine acceptance and visit experience. Am J Public Health. 2015;105(10):1998–2004. doi:10.2105/ajph.2014.302425. PMID: 25790386.
  • Constable C, Ferguson K, Nicholson J, Quinn GP. Clinician communication strategies associated with increased uptake of the human papillomavirus (HPV) vaccine: a systematic review. CA Cancer J Clin. 2022;72(6):561–9. doi:10.3322/caac.21753.
  • Dempsey AF, O’Leary ST. Human papillomavirus vaccination: narrative review of studies on how providers’ vaccine communication affects attitudes and uptake. Acad Pediatr. 2018;18(2, Supplement):S23–7. doi:10.1016/j.acap.2017.09.001.
  • Sturm L, Donahue K, Kasting M, Kulkarni A, Brewer NT, Zimet GD. Pediatrician-parent conversations about human papillomavirus vaccination: an analysis of audio recordings. J Adolesc Health. 2017;61(2):246–51. doi:10.1016/j.jadohealth.2017.02.006. PMID: 28455129.
  • Hofstetter AM, Robinson JD, Lepere K, Cunningham M, Etsekson N, Opel DJ. Clinician-parent discussions about influenza vaccination of children and their association with vaccine acceptance. Vaccine. 2017;35(20):2709–15. doi:10.1016/j.vaccine.2017.03.077. PMID: 28392141.
  • Moss JL, Reiter PL, Rimer BK, Brewer NT. Collaborative patient-provider communication and uptake of adolescent vaccines. Social Sci Med. 2016;159:100–7. doi:10.1016/j.socscimed.2016.04.030.
  • Opel DJ, Zhou C, Robinson JD, Henrikson N, Lepere K, Mangione-Smith R, Taylor JA. Impact of childhood vaccine discussion format over time on immunization status. Acad Pediatr. 2018;18(4):430–6. doi:10.1016/j.acap.2017.12.009. PMID: 29325912.
  • Dempsey AF, Pyrznawoski J, Lockhart S, Barnard J, Campagna EJ, Garrett K, Fisher A, Dickinson LM, O’Leary ST. Effect of a health care professional communication training intervention on adolescent human papillomavirus vaccination: a cluster randomized clinical trial. JAMA Pediatr. 2018;172(5):e180016. doi:10.1001/jamapediatrics.2018.0016. PMID: 29507952.
  • Gilkey MB, Grabert BK, Heisler-MacKinnon J, Bjork A, Boynton MH, Kim K, Alton Dailey S, Liu A, Todd KG. Coaching and communication training for HPV vaccination: a cluster randomized trial. Pediatrics. 2022;150(2). doi:10.1542/peds.2021-052351.
  • Reno JE, Thomas J, Pyrzanowski J, Lockhart S, O’Leary ST, Campagna EJ, Dempsey AF. Examining strategies for improving healthcare providers’ communication about adolescent HPV vaccination: evaluation of secondary outcomes in a randomized controlled trial. Hum Vaccin Immunother. 2019;15(7–8):1592–8. doi:10.1080/21645515.2018.1547607. PMID: 30433845.
  • Gilkey MB, Zhou M, McRee AL, Kornides ML, Bridges JFP. Parents’ views on the best and worst reasons for guideline-consistent HPV vaccination. Cancer Epidemiol Biomarkers Prev. 2018;27(7):762–7. doi:10.1158/1055-9965.Epi-17-1067. PMID: 29903744.
  • Malo TL, Gilkey MB, Hall ME, Shah PD, Brewer NT. Messages to motivate human papillomavirus vaccination: national studies of parents and physicians. Cancer Epidemiol Biomarkers Prev. 2016;25(10):1383–91. doi:10.1158/1055-9965.Epi-16-0224. PMID: 27694109.
  • McRee AL, Reiter PL, Chantala K, Brewer NT. Does framing human papillomavirus vaccine as preventing cancer in men increase vaccine acceptability? Cancer Epidemiol Biomarkers Prev. 2010;19(8):1937–44. doi:10.1158/1055-9965.Epi-09-1287. PMID: 20647398.
  • Porter RM, Amin AB, Bednarczyk RA, Omer SB. Cancer-salient messaging for human papillomavirus vaccine uptake: a randomized controlled trial. Vaccine. 2018;36(18):2494–500. doi:10.1016/j.vaccine.2018.01.040. PMID: 29599089.
  • Shah PD, Calo WA, Gilkey MB, Boynton MH, Alton Dailey S, Todd KG, Robichaud MO, Margolis MA, Brewer NT. Questions and concerns about HPV vaccine: a communication experiment. Pediatrics. 2019;143(2). doi:10.1542/peds.2018-1872. PMID: 30670584.
  • Kempe A, O’Leary ST, Markowitz LE, Crane LA, Hurley LP, Brtnikova M, Beaty BL, Meites E, Stokley S, Lindley MC. HPV vaccine delivery practices by primary care physicians. Pediatrics. 2019;144(4). doi:10.1542/peds.2019-1475. PMID: 31527175.
  • Shah PD, Calo WA, Gilkey MB, Margolis MA, Dailey SA, Todd KG, Brewer NT. Easing human papillomavirus vaccine hesitancy: a communication experiment with U.S. parents. Am J Prev Med. 2021;61(1):88–95. doi:10.1016/j.amepre.2021.02.009. PMID: 33975768.
  • Kornides ML, McRee AL, Gilkey MB. Parents who decline HPV vaccination: who later accepts and why? Acad Pediatr. 2018 Mar;18(2S):S37–43. doi:10.1016/j.acap.2017.06.008. PMID: 29502636.